Safety and dose modification for patients receiving niraparib von Berek, J.S., Matulonis, U.A., Peen, U., Ghatage, P., Mahner, S., Redondo, A., Lesoin, A., Colombo, N., Vergote, I., Rosengarten, O., Ledermann, J., Pineda, M., Ellard, S., Sehouli, J., Gonzalez-Martin, A., Berton-Rigaud, D., Madry, R., Reinthaller, A., Hazard, S., Guo, W., Mirza, M.R.

Volltext

Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I–type II study from the GINECO group von Heudel, P-E, Fabbro, M, Roemer-Becuwe, C, Kaminsky, M C, Arnaud, A, Joly, F, Roche-Forestier, S, Meunier, J, Foa, C, You, B, Priou, F, Tazi, Y, Floquet, A, Selle, F, Berton-Rigaud, D, Lesoin, A, Kalbacher, E, Lortholary, A, Favier, L, Treilleux, I, Ray-Coquard, I

Volltext

Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study von Joly, F., Ahmed-Lecheheb, D., Kalbacher, E., Heutte, N., Clarisse, B., Grellard, J.M., Gernier, F., Berton-Rigaud, D., Tredan, O., Fabbro, M., Savoye, A.M., Kurtz, J.E., Alexandre, J., Follana, P., Delecroix, V., Dohollou, N., Roemer-Becuwe, C., De Rauglaudre, G., Lortholary, A., Prulhiere, K., Lesoin, A., Zannetti, A., N’Guyen, S., Trager-Maury, S., Chauvenet, L., Abadie Lacourtoisie, S., Gompel, A., Lhommé, C., Floquet, A., Pautier, P.

Volltext

Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Mea... von Friedlander, M., Rau, J., Lee, C.K., Meier, W., Lesoin, A., Kim, J.-W., Poveda, A., Buck, M., Scambia, G., Shimada, M., Hilpert, F., King, M.T., Debruyne, P., Bologna, A., Malander, S., Monk, B.J., Petru, E., Calvert, P., Herzog, T.J., Barrett, C., du Bois, A.

Volltext

The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG... von Lenck, C., Chopin, N., Gouy, S., Bonsang-Kitzis, H., Martinez-Gomez, C., Radosevic-Robin, N., Martin, S., Lefeuvre-plesse, C., Lambaudie, E., Leblanc, E., Guyon, F., Classe, J.-M., Ramanah, R., Beurrier, F., Angeles, M.A., Pomel, C., Joly, F., de la Motte Rouge, T., Provansal, M., Lesoin, A., Floquet, A., Berton, D., Kalbacher, E., Chakiba, C., Meeus, P., Selle, F., Treilleux, I., Lecuru, F., Pautier, P., Ray-Coquard, I.

Volltext

Alienor/ENGOT-ov7 randomized trial exploring weekly paclitaxel (wP) + bevacizumab (bev) vs wP alone for patients with ovarian sex cord tumors (SCT) in relapse von Ray-Coquard, I.L., Harter, P., Lorusso, D., Dalban, C., Vergote, I.B., Fujiwara, K., Gladieff, L., Lueck, H.-J., Floquet, A., Lesoin, A.F., Schnelzer, A., Pignata, S., Selle, F., Sehouli, J., Brocard, F., Mangili, G., Pautier, P., De Giorgi, U., Provansal, M., Heudel, P.-E.

Volltext

Safety and dose modification for patients receiving niraparib von Berek, J S, Matulonis, U A, Peen, U, Ghatage, P, Mahner, S, Redondo, A, Lesoin, A, Colombo, N, Vergote, I, Rosengarten, O, Ledermann, J, Pineda, M, Ellard, S, Sehouli, J, Gonzalez-Martin, A, Berton-Rigaud, D, Madry, R, Reinthaller, A, Hazard, S, Guo, W, Mirza, M R

Volltext

Bcl-2 proteins expression and response to navitoclax in platinum resistant/refractory recurrent ovarian cancer (PROC) von Brachet, P.E., Joly Lobbedez, F., Fabbro, M., Leary, A., Medioni, J., Follana, P., Lesoin, A.F., Frenel, J.-S., Abadie Lacourtoisie, S., Floquet, A., Gladieff, L., You, B., Gavoille, C., Kalbacher, E., Briand, M., Just, P.A., Blanc-Fournier, C., Giffard, F., Clarisse, B., Poulain, L.

Volltext

Correction to: “Safety and dose modification for patients receiving niraparib” von Berek, J.S., Matulonis, U.A., Peen, U., Ghatage, P., Mahner, S., Redondo, A., Lesoin, A., Colombo, N., Vergote, I., Rosengarten, O., Ledermann, J., Pineda, M., Ellard, S., Sehouli, J., Gonzalez-Martin, A., Berton-Rigaud, D., Madry, R., Reinthaller, A., Hazard, S., Guo, W., Mirza, M.R.

Volltext

A phase II study of lenalidomide in platinum-sensitive recurrent ovarian carcinoma von Selle, F., Sevin, E., Ray-Coquard, I., Mari, V., Berton-Rigaud, D., Favier, L., Fabbro, M., Lesoin, A., Lortholary, A., Pujade-Lauraine, E.

Volltext

2757 Intraperitoneal (IP) chemotherapy (CT) in epithelial ovarian cancer (EOC): A matched case-control study von Kotecki, N, Tresch, E, Cousin, S, Chevalier, A, Vanlerenberghe, E, Bresson, L, Narducci, F, Leblanc, E, Lesoin, A

Volltext

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer von Mirza, Mansoor R, Monk, Bradley J, Herrstedt, Jørn, Oza, Amit M, Mahner, Sven, Redondo, Andrés, Fabbro, Michel, Ledermann, Jonathan A, Lorusso, Domenica, Vergote, Ignace, Ben-Baruch, Noa E, Marth, Christian, Mądry, Radosław, Christensen, René D, Berek, Jonathan S, Dørum, Anne, Tinker, Anna V, du Bois, Andreas, González-Martín, Antonio, Follana, Philippe, Benigno, Benedict, Rosenberg, Per, Gilbert, Lucy, Rimel, Bobbie J, Buscema, Joseph, Balser, John P, Agarwal, Shefali, Matulonis, Ursula A

Volltext

Results of a prospective dose-intensive regimen in 27 patients with small cell carcinoma of the ovary of the hypercalcemic type von Pautier, P., Ribrag, V., Duvillard, P., Rey, A., Elghissassi, I., Sillet-Bach, I., Kerbrat, P., Mayer, F., Lesoin, A., Brun, B., Crouet, H., Barats, J.C., Morice, P., Lhommé, C.

Volltext

2766 Safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Data from the ANTHALYA trial von Selle, F, Gouy, S, Lambaudie, E, Guyon, F, Fourchotte, V, Pomel, C, Colombo, P.E, Kalbacher, E, Martin-Francoise, S, Fauvet, R, Follana, P, Lesoin, A, Lecuru, F, Menguy, V, Ghazi, Y, Chereau, E, Zohar, S, Cottu, P, Joly, F, Rouzier, R

Volltext

2772 Circulating tumor cells kinetics in ovarian carcinoma: correlation with baseline characteristics and CA-125 levels in the randomized ANTHALYA trial evaluating bevacizumab in t... von Cottu, P, Rouge, T. De La Motte, Pautier, P, Provansal, M, Floquet, A, Selle, F, Mouret-Reynier, M.A, Fabbro, M, Kalbacher, E, Piprot, C, Follana, P, Lesoin, A, Medioni, J, Menguy, V, Ghazi, Y, Bidard, F.C, Dubot, C, Joly, F

Volltext

Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial von Kurtz, Jean-Emmanuel, Pujade-Lauraine, Eric, Oaknin, Ana, Belin, Lisa, Leitner, Katharina, Cibula, David, Denys, Hannelore, Rosengarten, Ora, Rodrigues, Manuel, de Gregorio, Nikolaus, Martinez García, Jeronimo, Petru, Edgar, Kocián, Roman, Vergote, Ignace, Pautier, Patricia, Schmalfeldt, Barbara, Gaba, Lydia, Polterauer, Stephan, Mouret Reynier, Marie-Ange, Sehouli, Jalid, Churruca, Cristina, Selle, Frédéric, Joly, Florence, D'Hondt, Véronique, Bultot-Boissier, Émilie, Lebreton, Coriolan, Lotz, Jean-Pierre, Largillier, Rémy, Heudel, Pierre-Etienne, Heitz, Florian

Volltext

Final results from GCIG/ENGOT/AGO‐OVAR 12, a randomised placebo‐controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer von Ray‐Coquard, Isabelle, Cibula, David, Mirza, Mansoor R., Reuss, Alexander, Ricci, Caterina, Colombo, Nicoletta, Koch, Horst, Goffin, Frédéric, González‐Martin, Antonio, Ottevanger, Petronella B., Baumann, Klaus, Bjørge, Line, Lesoin, Anne, Burges, Alexander, Rosenberg, Per, Gropp‐Meier, Martina, Harrela, Maija, Harter, Philipp, Frenel, Jean‐Sébastien, Minarik, Tomas, Pisano, Carmela, Hasenburg, Annette, Merger, Michael, Bois, Andreas

Volltext

Safety and dose modification for patients with low body weight receiving niraparib in the ENGOT-OV16/NOVA phase III trial von Lord, R., Mirza, M.R., Woelber, L., Lesoin, A., Pineda, M.J., Peen, U., Hazard, S.J., Matulonis, U.A.

Volltext

Functional MR Imaging: new tool to predict outcome for cervical carcinoma of uterus treated by concomitant radiochemotherapy? von Taïeb, S, Faivre-Pierret, M, Nickers, P, Lesoin, A, Narducci, F, Ceugnart, L

Volltext

Intracavitary Preoperative Brachytherapy Followed By Whertheim-Type Hysterectomy in Localized Cervical Cancer: Clinical Data and Toxicity Results from a Single Institution Experien... von Bataille, B., Le Tinier, F., Escande, A., Parent, A., Bogart, E., Narducci, F., Leblanc, E., Hudry, D., Lemaire, A.S., Lesoin, A., Chevalier, A., Taieb, S., Ben Haj Amor, M., Lartigau, E., Mirabel, X., Cordoba, A.

Volltext